Form 4 for EHC Encompass Health Corp
Accepted 2024-10-17 00:00:00 ET · period of report 2024-01-16 · accession 0001127602-24-025653 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-17 | 2024-01-16+ | EHC | CARMICHAEL GREG D | Dir | L - Small Acq | $80.51 | +14 | 13.1K | +0.1% | +$1,127 |
| 2024-10-17 | 2024-10-15 | EHC | CARMICHAEL GREG D | Dir | A - Grant | $0.00 | +24 | 17.1K | +0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Encompass Health Common Stock | 2024-07-15 | L | A | 7 | $86.89 | 17,088 | D | — | — | (F1) This acquisition is a dividend reinvestment administered by the reporting person's broker. It is eligible for deferred reporting on Form 5 pursuant to Rule 16a-6 but is being reported earlier than required on Form 4. |
| 2 | Common | Encompass Health Common Stock | 2024-04-15 | L | A | 3 | $81.47 | 13,079 | D | — | — | (F1) This acquisition is a dividend reinvestment administered by the reporting person's broker. It is eligible for deferred reporting on Form 5 pursuant to Rule 16a-6 but is being reported earlier than required on Form 4. |
| 3 | Common | Encompass Health Common Stock | 2024-01-16 | L | A | 4 | $68.64 | 13,055 | D | — | — | (F1) This acquisition is a dividend reinvestment administered by the reporting person's broker. It is eligible for deferred reporting on Form 5 pursuant to Rule 16a-6 but is being reported earlier than required on Form 4. |
| 4 | Common | Encompass Health Common Stock | 2024-10-15 | A | A | 24 | $0.00 | 17,112 | D | — | — | (F2) Pursuant to outstanding restricted stock unit award agreements, additional restricted stock units ("RSUs") are credited to each non-employee director's account in connection with common stock dividend payments. The number of RSUs credited is equal to (a) the product of (i) the number of the RSUs in each director's account on the associated dividend record date and (ii) the per share dividend, divided by (b) the closing price on the dividend payment date. On October 15, 2024, Encompass Health paid a dividend on its common stock of $0.17 per share and the closing price was $96.33. The transaction reported on this Form 4 is an award of RSUs associated with that dividend payment. |